Comprehensive Genomic Profile - 500 Gene Panel is an advanced next-generation sequencing (NGS) test that analyzes 500+ cancer-related genes from tumor tissue (usually FFPE). It detects a wide range of genomic alterations including mutations, insertions/deletions, copy number variations, gene fusions, and biomarkers like TMB (Tumor Mutational Burden) and MSI (Microsatellite Instability). This panel helps oncologists identify actionable mutations, guide targeted therapy selection, determine eligibility for clinical trials, and provide personalized treatment strategies for patients with solid tumors or advanced cancers.
It is a comprehensive test that often includes and expands beyond standard single-gene tests like EGFR, BRAF, or KRAS.
It is recommended for patients with advanced, metastatic, or rare solid tumors where standard treatment is not effective.
The 500 Gene Panel is much broader, covering more genes, rare alterations, TMB, and MSI compared to limited 10-50 gene panels.
It uses high-sensitivity NGS technology with excellent accuracy. Positive findings are usually confirmed with orthogonal methods for clinical reliability.
No actionable mutation means standard therapies or clinical trials based on other factors may be considered. It still provides valuable information.
...
Didn't recieved OTP Yet? Resend OTP